NCT02226276 2026-02-13
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
City of Hope Medical Center
Phase NA Active not recruiting
Clinical Trials
3 trialsNCT06299852 2024-03-08
Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer
N.N. Petrov National Medical Research Center of Oncology
Phase NA Unknown
NCT05560308 2022-10-03
Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown